Live feed/
Filings
/
SCHEDULE
/
0002050755-25-000014
Stake: 20.10%
Shares: 1,374,775
CUSIP: 929033108
Class: Common Stock, par value $.0001 per share
Item 4 — Purpose of Transaction
Item 4 of Schedule 13D is hereby amended and supplemented as follows: From October 8, 2025 through October 9, 2025, Reprogrammed Interchange LLC sold the following shares of Vor Biopharma Inc. in open market transactions, resulting in a decrease in the number of shares of Common Stock beneficially owned by the Reporting Persons by more than one percent of the outstanding shares of Common Stock of the Issuer. 1. 75,262 shares on October 8, 2025, at a weighted average per share sale price of $33.8651. 2. 48,884 shares on October 9, 2025, at a weighted average per share sale price of $32.068.
Cross-References
Insider Activity (last 365d)
1 transaction
0 buys · 1 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 4.10
5,687,983 shares short · +66.5% vs prior
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-04-17 |
RA CAPITAL MANAGEMENT, L.P. |
director, 10%+ owner |
Sale |
458,411 |
$16.28 |
$7.46M |
Other 13D/G Filings on Vor Biopharma Inc.
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2023-08-11 |
SC |
RA CAPITAL MANAGEMENT, L.P. |
— |
— |
view → |
| 2022-11-14 |
SC |
RA CAPITAL MANAGEMENT, L.P. |
— |
— |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.
Request a pilot →